Neurology--the next 10 years (Q46374782)

21 December 2017

title

Neurology--the next 10 years (English)

1 reference

21 December 2017

1 reference

21 December 2017

Michael Weller

object named as

Michael Weller

1 reference

21 December 2017

Annamaria Vezzani

1 reference

21 December 2017

Chetan Bettegowda

1 reference

21 December 2017

Sven Jarius

object named as

Sven Jarius

1 reference

21 December 2017

Brigitte Wildemann

object named as

Brigitte Wildemann

1 reference

21 December 2017

author name string

Ralf Baron

1 reference

21 December 2017

Donna M Ferriero

1 reference

21 December 2017

Ziya L Gokaslan

1 reference

21 December 2017

John A Kessler

1 reference

21 December 2017

Stephen G Waxman

1 reference

21 December 2017

language of work or name

English

0 references

publication date

27 October 2015

1 reference

21 December 2017

published in

Nature Reviews Neurology

1 reference

21 December 2017

volume

1 reference

21 December 2017

issue

1 reference

21 December 2017

page(s)

658-664

1 reference

21 December 2017

Subgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approach

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Feasibility and safety of erythropoietin for neuroprotection after perinatal arterial ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

The endogenous regenerative capacity of the damaged newborn brain: boosting neurogenesis with mesenchymal stem cell treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Mesenchymal stem cells as cellular vectors for pediatric neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Rare copy number variation in cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Clinically relevant copy number variations detected in cerebral palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

De novo mutations in epileptic encephalopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

The contribution of de novo coding mutations to autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

The clinical use of structural MRI in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

The A4 study: stopping AD before symptoms begin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Plasma phospholipids identify antecedent memory impairment in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Relation of Leisure-Time Physical Activity and Cardiorespiratory Fitness to the Risk of Acute Myocardial Infarction in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Molecular insights into pediatric brain tumors have the potential to transform therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Genome editing. The new frontier of genome engineering with CRISPR-Cas9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Moving stem cells to the clinic: potential and limitations for brain repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Non-viral vectors for gene-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

State-of-the-art gene-based therapies: the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Regenerative therapies for central nervous system diseases: a biomaterials approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Nanotechnology-novel therapeutics for CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

RNA interference. Drugging RNAi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Mechanisms of epileptogenesis and potential treatment targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Anti-inflammatory drugs in epilepsy: does it impact epileptogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Development of new antiepileptic drugs: challenges, incentives, and recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Past and present definitions of epileptogenesis and its biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Brain inflammation as a biomarker in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

The challenge and promise of anti-epileptic therapy development in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Animal models in epilepsy research: legacies and new directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Reprogramming patient-derived cells to study the epilepsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

WONOEP appraisal: optogenetic tools to suppress seizures and explore the mechanisms of epileptogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Neuroimaging the epileptogenic process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

WONOEP appraisal: new genetic approaches to study epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Identifying targets for preventing epilepsy using systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Mechanisms underlying epilepsies associated with sodium channel mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Sodium channels, inherited epilepsy, and antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Divergent sodium channel defects in familial hemiplegic migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Gain of function NaV1.7 mutations in idiopathic small fiber neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

The Na(V)1.7 sodium channel: from molecule to man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Sodium channel blockers: a patent review (2010 - 2014).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Structural modelling and mutant cycle analysis predict pharmacoresponsiveness of a Na(V)1.7 mutant channel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Sensory neuron-specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

'Medusa-head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 1: Anti-mGluR1, anti-Homer-3, anti-Sj/ITPR1 and anti-CARP VIII

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 2: Anti-PKC-gamma, anti-GluR-delta2, anti-Ca/ARHGAP26 and anti-VGCC

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

'Medusa head ataxia': the expanding spectrum of Purkinje cell antibodies in autoimmune cerebellar ataxia. Part 3: Anti-Yo/CDR2, anti-Nb/AP3B2, PCA-2, anti-Tr/DNER, other antibodies, diagnostic pitfalls, summary and outlook

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

The spectrum of MOG autoantibody-associated demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Acute stroke intervention: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Genetic insights in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Presence of hyperalgesia predicts analgesic efficacy of topically applied capsaicin 8% in patients with peripheral neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Cooling for newborns with hypoxic ischaemic encephalopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Seizure prediction for therapeutic devices: A review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Immunopathology of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Physical rehabilitation approaches for the recovery of function and mobility following stroke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2015.196

Whole Exome Sequencing Reveals DYSF, FKTN, and ISPD Mutations in Congenital Muscular Dystrophy Without Brain or Eye Involvement

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26503922

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Evolution and prospects for intracranial pharmacotherapy for refractory epilepsies: the subdural hybrid neuroprosthesis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26503922

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEUROL.2015.196

1 reference

21 December 2017

Dimensions Publication ID

1010549822

0 references

1 reference

21 December 2017